Plaintiffs Tell 9th Circuit Incretin Mimetic MDL Court Got Preemption Law Wrong

(September 8, 2016, 1:05 PM EDT) -- SAN FRANCISCO — The incretin mimetic multidistrict litigation court misinterpreted U.S. Supreme Court preemption law in dismissing the MDL, plaintiffs tell the Ninth Circuit U.S. Court of Appeals in a Sept. 6 reply brief (In Re: Incretin-Based Therapies Products Liability Litigation, Jean Adams, et al. v. Merck Sharp & Dohme Corp., et al., No. 15-56997, 9th Cir.).

(Brief available. Document #28-160915-001B.)

In November, U.S. Judge Anthony J. Battaglia of the Southern District of California granted summary judgment to the defendants, finding "clear evidence" that the Food...
To view the full article, register now.